BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, July 14, 2025
See today's BioWorld Asia
Home
» SK Bioscience developing combo flu and COVID-19 vaccine, a first of its kind in South Korea
To read the full story,
subscribe
or
sign in
.
SK Bioscience developing combo flu and COVID-19 vaccine, a first of its kind in South Korea
March 1, 2022
By
Gina Lee
SK Bioscience Ltd. is developing a vaccine intended to simultaneously immunize people against the flu and COVID-19.
BioWorld Asia
Infection
Coronavirus
Vaccine
Asia-Pacific
